Pharmacy Chain 36.6 Sales Drop 19%, Outlook More Stable Going Forward

A challenging year for Russian pharmaceutical enterprise Pharmacy Chain 36.6 is reflected in the firm's financial results for 2009, which recorded a drop in consolidated revenues of 19.1% year-on-year (y-o-y) in rouble terms. The firm, which has had to deal with difficulties in raising capital, declines in consumer demand and deteriorating relations with suppliers. While 2009 financial indicators are less than positive, BMI's optimistic outlook for the domestic pharmaceutical market should allow the firm to continue to grow over the medium term should it resolve any lingering

To read the full article, please choose one of the following options: